KPNB1 and cervical cancer: Targeting KPNB1 as a means of transcription factor inhibition may be a favorable approach as KPNB1 is overexpressed in cervical cancer tissue in comparison to normal cervical tissue and we have previously shown that normal cells are less dependent on KPNB1 for proliferation and survival [5].